1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPublic Health Equity Grant is sponsored by Oregon Health Authority. Supports community-based organizations addressing health inequities in areas like communicable disease prevention, immunizations, and overdose prevention.
Get alerted about grants like this
Save a search for “Oregon Health Authority” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Oregon Health Authority : OHA partners with 125 Oregon CBOs to advance public health equity : External Relations Division : State of Oregon Translate this site into other Languages tag, as divs are not allowed in 's --> OHA partners with 125 Oregon CBOs to advance public health equity Agency provides $25 million to support adolescent health, communicable disease prevention, seven other program areas PORTLAND, Ore.
—Oregon Health Authority (OHA) has awarded $25 million in public health equity grants to 125 nonprofit organizations to support work on community-led and culturally and linguistically responsive programs. The funding through OHA’s Partnerships for Community Health Program covers nine program areas and supports the work of community-based organizations between Jan. 1, 2026, and June 30, 2027.
“The response to this grant was remarkable — more than 800 applications from community-based organizations committed to supporting public health in Oregon, reviewed through a collaborative effort between state and local public health,” said OHA Public Health Director Naomi Adeline-Biggs.
The Partnerships for Community Health Program will work with CBOs and programs within the Public Health Division to engage communities on long-term public health efforts in the following areas: Adolescent and School Health Communicable Disease Prevention: Immunizations Communicable Disease Prevention: Prevention of HIV, Sexually Transmitted Infections, and Tuberculosis Commercial Tobacco Prevention Community Resilience: Community Connection & Empowerment Community Resilience: Emergency Preparedness and Response Environmental Public Health Preventing Environmental Exposures for Children’s Health (PEECH) View the list of grant recipients .
“I want to recognize the dedication of the many reviewers who brought both expertise and care to this work. Local public health leaders played a critical role alongside state partners to ensure a thoughtful, equitable and conscientious review,” said Adeline-Biggs. “That same collaboration will be essential as we move forward with communities to support meaningful, lasting change.
” Through the grants, OHA seeks to improve health outcomes with increased access to health care and prevention services for everyone in Oregon. OHA recognizes that past and present policies, barriers in systems such as health care and housing, and lasting social and economic challenges, have made it harder for some communities to be healthy and create futures they want for themselves and their families.
Differences in income, education and opportunities have led to critical and persistent health gaps.
Some communities most affected by health inequities include communities of color, Tribal communities, persons with disabilities, members of immigrant and refugee communities, undocumented populations, migrant and seasonal farmworkers, LGBTQIA2S+ individuals, faith-based communities, people living with lower incomes, older adults, rural communities, individuals without stable housing and others.
OHA’s commitment to eliminating health inequities by 2030 relies on building trusting relationships with community-based organizations that collectively serve every county, and on supporting their efforts to uplift community health priorities that are grounded in equity and accessibility. PHD. Communications@oha.
oregon. gov How to recognize an official Oregon website Only share sensitive information on official, secure websites. Your browser is out-of-date!
It has known security flaws and may not display all features of this and other websites. Learn how
Based on current listing details, eligibility includes: Community-based organizations in Oregon. ([oregon. gov](https://www. oregon. gov/oha/PH/ABOUT/Pages/Public-Health-Equity-Grant. aspx? utm_source=openai)) Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Varies Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.